Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Pedro Marques Ramos"'
Autor:
Pedro Marques Ramos, Jeea Choi, Catarina D. Campbell, Ying A. Wang, Celine Pallaud, Michael Dickinson, Amit Verma, Moshe Mittelman, Uwe Platzbecker, Honar Cherif, Pierre Fenaux
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 876-881 (2023)
Abstract Eltrombopag has been previously shown to be effective in reversing azacitidine‐mediated thrombocytopenia. This was further investigated in the SUPPORT trial, a phase III study assessing the efficacy/safety of eltrombopag plus azacitidine i
Externí odkaz:
https://doaj.org/article/1a4eb4e4b59b4fa7b1cc250080b778b7
Autor:
Federica Zilli, Pedro Marques Ramos, Priska Auf der Maur, Charly Jehanno, Atul Sethi, Marie‐May Coissieux, Tobias Eichlisberger, Loïc Sauteur, Adelin Rouchon, Laura Bonapace, Joana Pinto Couto, Roland Rad, Michael Rugaard Jensen, Andrea Banfi, Michael B Stadler, Mohamed Bentires‐Alj
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 4, Pp n/a-n/a (2021)
Abstract Metastasis is the main cause of deaths related to solid cancers. Active transcriptional programmes are known to regulate the metastatic cascade but the molecular determinants of metastatic colonization remain elusive. Using an inducible pigg
Externí odkaz:
https://doaj.org/article/42ad8c50455f42c9bfe8d2e92e8ddc15
Autor:
Valeria Santini, Uwe Platzbecker, Pierre Fenaux, Aristoteles Giagounidis, Yasushi Miyazaki, Mikkael A. Sekeres, Zhijian Xiao, Guillermo Sanz, Marlies Van Hoef, Fei Ma, Sabine Hertle, Pedro Marques Ramos, Amer M. Zeidan
Publikováno v:
Blood. 140:1340-1342
Autor:
Ujunwa Cynthia Okoye-Okafor, Komal K. Javarappa, Dimitrios Tsallos, Joseph Saad, Daozheng Yang, Chi Zhang, Lumie Benard, Victor J. Thiruthuvanathan, Sally Cole, Stephen Ruiz, Madhuri Tatiparthy, Gaurav Choudhary, Stefanie DeFronzo, Boris A. Bartholdy, Celine Pallaud, Pedro Marques Ramos, Aditi Shastri, Amit Verma, Caroline A. Heckman, Britta Will
Publikováno v:
Journal of Experimental Medicine. 219
Publisher Copyright: © 2022 Okoye-Okafor et al. Thrombocytopenia, prevalent in the majority of patients with myeloid malignancies, such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), is an independent adverse prognostic factor. A
Autor:
Amer M. Zeidan, Amy E. DeZern, Uma Borate, Krissy Kobata, Susan E. Ide, John Sabo, Pedro Marques Ramos, Haiying Sun, Roger M. Lyons, Guillermo Garcia-Manero
Publikováno v:
Blood. 140:4069-4070
Autor:
Amer M. Zeidan, Kiyoshi Ando, Odile Rauzy, Mehmet Turgut, Ming-Chung Wang, Roberto Cairoli, Hsin-An Hou, Yok-Lam Kwong, Montserrat Arnan Sangerman, Stef Meers, Vinod A. Pullarkat, Valeria Santini, Kamel Malek, Flavia Kiertsman, Jiaying Lyu, Pedro Marques Ramos, Pierre Fenaux, Yasushi Miyazaki, Uwe Platzbecker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c141ab9d0ac7d7d5923b5c0a6f03c6
https://hdl.handle.net/10281/411282
https://hdl.handle.net/10281/411282
Autor:
Amer M. Zeidan, Amy DeZern, Uma Borate, Krissy Kobata, Islam Sadek, J. Randy Sabo, Das Purkayastha, Pedro Marques Ramos, Haiying Sun, Roger Lyons, Guillermo Garcia-Manero
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S348-S349
Autor:
Satu Mustjoki, Aleksandr Ianevski, Panu E. Kovanen, Freja Ebeling, Tero Aittokallio, Oscar Brück, Helena Hohtari, Kimmo Porkka, Susanna Lallukka-Brück, Pedro Marques Ramos, Soili Kytölä
Publikováno v:
Blood Cancer Discov
In myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN), bone marrow (BM) histopathology is assessed to identify dysplastic cellular morphology, cellularity, and blast excess. Yet, other morphologic findings may elude the human eye. W
Autor:
Mette Ilander, Katja Välimäki, Olli Kallioniemi, Antonio Ribeiro, Oscar Brück, Teijo Pellinen, Olli Dufva, Kimmo Porkka, Celine Pallaud, Panu E. Kovanen, Riku Turkki, Satu Mustjoki, Sami Blom, Pedro Marques Ramos, Hanna Lähteenmäki, Helena Hohtari, Mohamed El Missiry
The immunologic microenvironment in various solid tumors is aberrant and correlates with clinical survival. Here, we present a comprehensive analysis of the immune environment of acute myeloid leukemia (AML) bone marrow (BM) at diagnosis. We compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a06d4d9dec677b5e38a5e3e38e26048
https://europepmc.org/articles/PMC6988390/
https://europepmc.org/articles/PMC6988390/
Autor:
Islam Sadek, Uma Borate, Amy E. DeZern, J. Randy Sabo, Pedro Marques Ramos, Das Purkayastha, Haiying Sun, Krissy Kobata, Roger M. Lyons, Amer M. Zeidan, Guillermo Garcia-Manero
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S230